Despite achieving record revenue, Cytek Biosciences Inc (CTKB) faces profitability pressures due to increased costs and a net loss in Q4 2025.

Thermo Fisher Scientific TMO has unveiled its latest innovation, the spectral-enabled Invitrogen Attune Xenith Flow Cytometer. The solution allows immunology and immuno-oncology researchers to ...

Waters has completed its combination with BD’s Biosciences and Diagnostic Solutions units, forming a global life sciences and diagnostics company spanning analytical sciences, biosciences, advanced ...

As an original manufacturer, Cloud-Clone redefines lab efficiency with high-sensitivity multiplex kits, offering a ...

Turning to the acquired business contribution, following today's expected close of the transaction, we expect the Biosciences ...

This insight explores the $1.1B primary cell market, highlighting how leaders like Lonza, Thermo Fisher, Cloud-Clone, ...

Waters Corporation (NYSE:WAT) Q4 2025 Earnings Call Transcript February 9, 2026 Waters Corporation beats earnings expectations. Reported EPS is $4.53, expectations were $4.5. Operator: Good morning ...

Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications Announces ...

STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.

Q4 2025 Earnings Call February 9, 2026 8:30 AM ESTCompany ParticipantsCaspar Tudor - Head of Investor RelationsUdit Batra ...

The UPLC system was configured with an Acquity Premier Oligonucleotide C18 column (1.7 µm, 2.1 × 50 mm). The aqueous and ...

Allied Market Research published a report, titled, "Allergy Immunotherapy Market by Type (Subcutaneous Immunotherapy and ...